SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-022392
Filing Date
2020-05-07
Accepted
2020-05-07 08:10:56
Documents
5
Period of Report
2020-05-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ovid-8k_20200507.htm 8-K 30816
2 EX-99.1 ovid-ex991_6.htm EX-99.1 94755
3 EX-99.2 ovid-ex992_7.htm EX-99.2 76452
4 GRAPHIC gfsdasdfqvnb000001.jpg GRAPHIC 4278
5 GRAPHIC gfs1uisi4cr0000001.jpg GRAPHIC 4278
  Complete submission text file 0001564590-20-022392.txt   215282
Mailing Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036
Business Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036 212-776-4381
Ovid Therapeutics Inc. (Filer) CIK: 0001636651 (see all company filings)

IRS No.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38085 | Film No.: 20854667
SIC: 2834 Pharmaceutical Preparations